Sentences with phrase «new shares of stock»

Shareholders in The Bank of Santa Barbara will receive.8546 shares of stock in American Riviera for each share they currently own; American Riviera will issue 1,586,000 new shares of stock to complete the transaction.

When you receive a dividend you keep it in your account as long as you accumulate enough to buy new shares of any stock you choose.

The underwriting process for bonds is less complicated than the procedures for issuing and selling new shares of stock.

Investment banks help corporations issue new shares of stock in an initial public offering or follow - on offering.

A secondary offering is when a company releases new shares of its stock after the initial public offering (IPO).

A stock buyback is basically a secondary offering in reverse — instead of selling new shares of stock to the public to put more cash on the corporate balance sheet, a cash - rich company expends some of its own funds on buying shares of stock from the public.

Not exact matches

Blackberry Ltds New York Stock Exchange - listed shares, for example, were trading as of 3:08 p.m. EDT, but the companys TSX - listed shares had not traded since 1:38 p.m.

Looking at individual stocks, shares of French food group Danone were over 1.5 percent higher on Monday after the New York Post reported that the firm could be a takeover target.

Shares of Spotify Technology SA are set to begin trading on the New York Stock Exchange on April 3 in an unusual direct listing that gives insiders the option to sell instantly and does without the support of traditional underwriters - a recipe for potentially high volatility in early trading.

The company's board put a special provision in Papa's employment agreement that turbocharges his pay the way a videogame might when a player levels up into bonus points mode: If Valeant's stock price reaches a new high of at least $ 270 a share in the next three years, Papa gets double the allotment of performance - based stock.

Apple's stock dipped at the start of 2016 due to concerns over a slowdown in iPhone sales, though share prices have since rebounded into positive territory for the year amid investor optimism for the company's new line of products.

The news and data provider has a market value of about US$ 31bn and its shares trade on the New York and Toronto stock exchanges.

One person familiar with the matter said that a group of investors including SoftBank, Dragoneer Investment Group and General Atlantic would be allowed to buy $ 1 billion to $ 1.25 billion of new Uber shares at a company valuation of $ 69 billion and 14 to 17 % of stock from current investors at a discounted valuation.

Ma reaped more than $ 800 million selling shares in the company he set up 15 years ago as Alibaba listed on the New York Stock Exchange Friday, based on company filings, with the value of his remaining stake of 7.8 percent surging to more than $ 17 billion by Monday.

NEW YORK, April 13 - Oil prices extended recent gains and a gauge of global stocks eased on Friday as concern over a broader conflict in Syria left investors nervous, while U.S. bank shares led Wall Street lower.

McDermott has served the energy industry since 1923, and shares of its common stock are listed on the New York Stock Exchstock are listed on the New York Stock ExchStock Exchange.

Pandora's shares will now debut on the New York Stock Exchange and sell at a price between $ 10 and $ 12, up from the company's original IPO pricing of between $ 7 and $ 9.

In late May, when Edward Yruma of Keybanc Capital Markets downgraded the stock, his reservations had more to do with its shares already being priced for perfection at a time when its strategy seemed to be shifting toward testing new products and markets more than driving sales in its yogawear stronghold.

NEW YORK --(BUSINESS WIRE)-- The Board of Directors of Citigroup Inc. today declared a quarterly dividend on Citigroup's common stock of $ 0.32 per share, payable on May 25, 2018 to stockholders of record on May 7, 2018.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

The pricing details were an update that Shake Shack provided in its latest regulatory filing, a key step as it moves forward to raise millions of dollars by launching its shares on the New York Stock Exchange.

World stocks rose 20 percent last year, significantly outpacing the average on bond markets, meaning the relative value of funds» equity holdings has increased without a single new share being bought.

The company has raised $ 555 million in the process by selling 37 million shares ahead of its debut on the New York Stock Exchange on Friday.

After giving $ 100 million to Newark, New Jersey schools, $ 120 million to Bay Area schools, and 18 million Facebook shares (now worth $ 1.9 billion) to the Silicon Valley Community Foundation, they made the audacious announcement that they would give away 99 % of their Facebook stock during their lifetime, an amount currently valued at $ 45 billion.

Stringer, who is leading the effort to vote down Mylan's current board, oversees New York City pensions that together own more than 1.1 million shares of Mylan stock.

Shares of Overstock.com fall after the company announces its intention to offer 4 million shares of new Shares of Overstock.com fall after the company announces its intention to offer 4 million shares of new shares of new stock.

After shares of Aéropostale slid Thursday on bankruptcy fears, the company was delisted by the New York Stock Exchange early Friday.

NEW YORK --(BUSINESS WIRE)-- Cowen Inc. (NASDAQ: COWN)(«Cowen» or the «Company) today announced that its board of directors has declared a quarterly cash dividend of $ 14.06 per share on the Company's 5.625 % Series A Cumulative Perpetual Convertible Preferred Stock (the «Convertible Preferred Stock»).

And in 2007, with crude prices on the rise, voracious demand for new shares of PetroChina on the Shanghai Stock Exchange caused the Chinese oil and gas company's market value to briefly top $ 1 trillion.

Barnes & Noble shares closed down 5.4 percent on the New York Stock Exchange after the company also reported a much - weaker - than - expected quarterly profit, due to lower sales of Nook devices.

The offering consisted of Tesla selling approximately $ 1.7 billion of new stock while Musk exercised stock options for over 5.5 million shares that were set to expire on Dec. 3, 2016 and then sold nearly 2.8 million of those shares.

More than 200 million shares — the entire size of the offering — changed hands over the course of the day, accounting for roughly 10 percent of the total volume of trading on the New York Stock Exchange on Thursday.

Next, the corporation issues all of its stock and transfers it to the new profit - sharing plan in exchange for the cash in the plan.

Patrick Jahnke, portfolio manager at Deka Investments, which owns BASF stock, said he favored the firm selling its upstream petrochemical assets, saying the benefits of physical proximity to downstream operations could be shared with a new owner.

It's a concern shared by many investors, who have been bailing out of Apple's stock amid tougher competition for the iPhone and the iPad and the lack of a new product line since Tim Cook became the company's CEO shortly before Jobs» death.

Since the growth is not measured on a per share basis, Rosenstein claims management can drive up its payout by acquiring new production volume, even if it means diluting the value of its shares to purchase Rice's wells with stock, which Rosenstein believes is undervalued.

SABMiller's strategic shareholders, who hold 41 % of the company's stock, would receive a lower offer worth 37.49 a share paid overwhelmingly in the form of a new class of unlisted share with a five - year lock - up period (a premium of only 28 %).

The company, headquartered in China and listed on the New York Stock Exchange, saw its stock climb 47.39 percent to $ 18.32 a share by the close of the U.S. trading session WedneStock Exchange, saw its stock climb 47.39 percent to $ 18.32 a share by the close of the U.S. trading session Wednestock climb 47.39 percent to $ 18.32 a share by the close of the U.S. trading session Wednesday.

In a model produced by New Street Research analyst Jonathan Chaplin on Friday, AT&T might pay $ 110 a share for Time Warner, with a split of 56 % in new stock and 44 % in cash raised from borrowiNew Street Research analyst Jonathan Chaplin on Friday, AT&T might pay $ 110 a share for Time Warner, with a split of 56 % in new stock and 44 % in cash raised from borrowinew stock and 44 % in cash raised from borrowing.

Following the completion of the transaction, Nimble shares will be delisted from the New York Stock Exchange.

The statement of claim also alleges that Ferro massively diluted the existing shareholders by issuing Soon - Shiong shares worth about 13 % of the company (Tribune says «The stock sales to Merrick Media and Nant Capital were approved by the Board of Directors and will provide valuable growth capital to allow the company to execute on its new value - creating business plan).

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

That's because many big enterprises regularly issue more stock than they buy back, using the proceeds for repurchase of new shares from newly exercised options and vested restricted stock, for M&A, and for secondary offerings.

Top - line details: Honest's new round would be Series E stock priced at around $ 19.60 per share, which is 57 % lower than the price of its Series D shares (sold in the summer of 2015).

On Thursday, China - based NetQin, a mobile security services company, went public on the New York Stock Exchange, pricing at $ 11.50 a share, the top of its range.

This number is calculated using the share counting rules described in Sections 5 (a) and 5 (b) of the 2014 Plan and includes the number of shares available for new award grants under the 2014 Plan out of the 385 million shares authorized by shareholders upon adoption of the 2014 Plan; the number of shares available for new award grants under the 2003 Employee Stock Plan (the «2003 Plan») on the date that shareholders approved the 2014 Plan; the number of shares subject to outstanding stock options under the 2003 Plan and 2014 Plan as of November 17, 2015; and two times the number of shares subject to outstanding RSUs under the 2003 Plan and 2014 Plan as of November 17, 2015 (all adjusted for the 7 - for - 1 stock spStock Plan (the «2003 Plan») on the date that shareholders approved the 2014 Plan; the number of shares subject to outstanding stock options under the 2003 Plan and 2014 Plan as of November 17, 2015; and two times the number of shares subject to outstanding RSUs under the 2003 Plan and 2014 Plan as of November 17, 2015 (all adjusted for the 7 - for - 1 stock spstock options under the 2003 Plan and 2014 Plan as of November 17, 2015; and two times the number of shares subject to outstanding RSUs under the 2003 Plan and 2014 Plan as of November 17, 2015 (all adjusted for the 7 - for - 1 stock spstock split).

Echelon is now focusing its growth on «smart» commercial & municipal LED lighting (although its fab-less chip business has apparently now stabilized after a long decline), and if the lighting business accelerates (and it could, due to recent sales force hires and new products), I think there's a chance it can hit a break - even annualized revenue run - rate of $ 40 million by Q4 - 2019 (pushed back from my earlier hoped - for timeline) at which point — assuming $ 14 million of remaining net cash (vs. an estimated $ 18 million at the end of Q2 2018) and 4.7 million shares outstanding (vs 4.52 million today), an enterprise value of 1x revenue on this 53 % gross margin company would put the stock in the mid - $ 11s per share.

That being said, the lack of progress in NXP's merger with Qualcomm continues to weigh on this stock, and the limited amount of new merger information in this release probably played a larger part in today's plunging share price than the actual report.

«Parent Trading Price» shall mean the average closing sales price of one (1) share of Parent Common Stock as reported on the New York Stock Exchange for the ten (10) consecutive trading days ending on the date that is two (2) trading days immediately preceding the Closing Date (as adjusted as appropriate to reflect any stock splits, stock dividends, combinations, reorganizations, reclassifications or similar eveStock as reported on the New York Stock Exchange for the ten (10) consecutive trading days ending on the date that is two (2) trading days immediately preceding the Closing Date (as adjusted as appropriate to reflect any stock splits, stock dividends, combinations, reorganizations, reclassifications or similar eveStock Exchange for the ten (10) consecutive trading days ending on the date that is two (2) trading days immediately preceding the Closing Date (as adjusted as appropriate to reflect any stock splits, stock dividends, combinations, reorganizations, reclassifications or similar evestock splits, stock dividends, combinations, reorganizations, reclassifications or similar evestock dividends, combinations, reorganizations, reclassifications or similar events).

New York - based drugmaker and Dow - 30 component Pfizer (PFE — Free Pfizer Stock Report) reported first - quarter earnings of $ 0.59 a share, versus $ 0.51 in the comparable period of 2017.